Saba Shaikh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saba Shaikh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jaiprakash Navnath Sangshetti
Y. B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza Baugh, Aurangabad, MS, India
1 shared publication - Manash Paul
Department of Radiation Biology and Toxicology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, 576104, India., India
1 shared publication - Mohd Sayeed Shaikh
Y. B. Chavan College of Pharmacy, Aurangabad, India
1 shared publication - Rana Zainuddin Ahmed
Y. B. Chavan College of Pharmacy, Aurangabad, India
1 shared publication - Rohidas B. Arote
Centre for Nano and Material Sciences. JAIN (Deemed-to-be) University, Bengaluru -562112, India, India
1 shared publication - Shahbaz Shaikh
Y. B. Chavan College of Pharmacy, Rauza Bagh Aurangabad, 431001, India, India
1 shared publication
Latest Publications
- Open Access
- 13 January 2026
- Published by MDPI AG in Preprints.org
Unlocking Nano-Drug Potential: Revolutionizing In Vitro Dissolution Testing for Nanomedicines
In-vitro dissolution study is crucial for quality assurance and stability, serving as a surrogate test for evaluating in-vivo performance of a drug. The dissolution procedure should be designed using an appropriate validated approach, depending on the type of dosage form. Dissolution testing is crucial to regulatory decision-making in a number of aspects. Conventional formulations have validated regulatory-compliant dissolution methods, conversely novel drug formulations like nanoparticles and microparticles lack standard validated procedures for the same. The present article provides information about the various compendial and non-compendial methods available for in-vitro dissolution testing of nano-formulations including the selection of dissolution media, different factors affecting the release, advancements in the dissolution procedures and also included the recently developed marketed nano-formulations.
- 13 January 2026
- Published by MDPI AG in Preprints.org
Open AccessUnlocking Nano-Drug Potential: Revolutionizing In Vitro Dissolution Testing for Nanomedicines
In-vitro dissolution study is crucial for quality assurance and stability, serving as a surrogate test for evaluating in-vivo performance of a drug. The dissolution procedure should be designed using an appropriate validated approach, depending on the type of dosage form. Dissolution testing is crucial to regulatory decision-making in a number of aspects. Conventional formulations have validated regulatory-compliant dissolution methods, conversely novel drug formulations like nanoparticles and microparticles lack standard validated procedures for the same. The present article provides information about the various compendial and non-compendial methods available for in-vitro dissolution testing of nano-formulations including the selection of dissolution media, different factors affecting the release, advancements in the dissolution procedures and also included the recently developed marketed nano-formulations.